Transcend Capital Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,435
| Closed | -$371K | – | 533 |
|
|
2023
Q4 | $371K | Hold |
1,435
| – | – | 0.03% | 350 |
|
|
2023
Q3 | $369K | Sell |
1,435
-35
| -2% | -$9K | 0.04% | 342 |
|
|
2023
Q2 | $419K | Sell |
1,470
-118
| -7% | -$33.6K | 0.04% | 324 |
|
|
2023
Q1 | $442K | Sell |
1,588
-1,657
| -51% | -$461K | 0.05% | 302 |
|
|
2022
Q4 | $899K | Sell |
3,245
-600
| -16% | -$166K | 0.1% | 211 |
|
|
2022
Q3 | $1.03M | Buy |
3,845
+11
| +0.3% | +$2.94K | 0.11% | 192 |
|
|
2022
Q2 | $782K | Buy |
3,834
+1,809
| +89% | +$369K | 0.08% | 231 |
|
|
2022
Q1 | $426K | Buy |
2,025
+600
| +42% | +$126K | 0.04% | 342 |
|
|
2021
Q4 | $342K | Buy |
1,425
+38
| +3% | +$9.12K | 0.03% | 359 |
|
|
2021
Q3 | $376K | Hold |
1,387
| – | – | 0.03% | 336 |
|
|
2021
Q2 | $480K | Buy |
+1,387
| New | +$480K | 0.07% | 210 |
|
|
2020
Q4 | – | Sell |
-771
| Closed | -$219K | – | 378 |
|
|
2020
Q3 | $219K | Buy |
+771
| New | +$219K | 0.04% | 235 |
|